Provention Bio diabetes drug to cost $13,850/vial Reuters Nov 22, 2022 The US Food and Drug Administration (FDA) approved use of the drug, to be sold under brand name Tzield, for delaying the onset of…
FDA approval of Provention Bio’s Teplizumab could bring first disease-modifying therapy to type 1… EP News Bureau Nov 27, 2020 If Provention Bio’s rolling Biologic License Application (BLA) submission to the FDA for teplizumab is approved, teplizumab will…
